HUNTSMAN RONALD KIRK (Chairman & CEO) purchased 26.1% of their position (15.02K shares) of VIVOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $8.1K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 6/20/2023ACC: 0001493152-23-021751
DirectorOfficer10% Owner· Chairman & CEO
Since Dec 2020
+15.02K
Net shares
Net buyer
$8.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
15.02K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+21.00
Price / share
$0.50
Trade value
$10.50
% of position
0.0%
6/15/2023
57.50K→57.52K
Common Stock
Direct
Shares
+10K
Price / share
$0.54
Trade value
$5.40K
% of position
17.4%
6/16/2023
57.52K→67.52K
Common Stock
Direct
Shares
+5K
Price / share
$0.53
Trade value
$2.65K
% of position
7.4%
6/16/2023
67.52K→72.52K
Total
Net shares
+15.02K
Net value
$8.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2023 | P · Purchase | +21.00 | $0.50 | $10.50 | 0.0% | 57.50K | 57.52K |
| Common Stock Direct | 6/16/2023 | P · Purchase | +10K | $0.54 | $5.40K | 17.4% | 57.52K | 67.52K |
| Common Stock Direct | 6/16/2023 | P · Purchase | +5K | $0.53 | $2.65K | 7.4% | 67.52K | 72.52K |
| Total | +15.02K | $8.06K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74M
Total
1.74M indirect1.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74M | Indirect |
| Total | 1.74M | 1.74M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported